An extension trial revealed that long-term anifrolumab treatment improved health status and health-related quality of life in ...

Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

Smile Group hires a former AstraZeneca executive to spearhead its new HealthTech venture studio, aiming to drive innovation ...

EMA committee recommends approval of AstraZeneca’s Imfinzi to treat adult patients with resectable muscle-invasive bladder cancer: Cambridge, UK Tuesday, May 27, 2025, 15:00 Hrs ...

Nvidia has announced plans to build an AI data center in Sweden. The chipmaker will partner with the Swedish Business ...

After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers ...

Dr. Bika holds a Ph.D. in Materials Science and Engineering from the University of Pennsylvania, a Master of Science in ...

Taking a statin medication is an effective, safe, and low-cost way to lower cholesterol and reduce risk of cardiovascular events. Despite clinicians recommending that many patients with diabetes take ...